Skip to content

FARMACON

Active Private limited companyfounded 1989active for 36 yearsGentse Steenweg 450, 9160 LokerenKBO/BCE: BE 0439.169.181 subsidiary of

Lifetime

20 annual accounts with figures on one time axis, 36 filings since 1990
peak of €293,299 in 2025
€293,299▲ 23.3%
lowest -€167,325 in 2011
€16,845▲ €65,359
peak of €229,617 in 2025
€229,617▲ 7.9%
€700,285▼ 14.1%
peak of 4 FTE in 2017
2.7 FTE▼ 10.0%
Board2 names since 2012
2 directors and 1 other
Owners
99.73%
Documentsfilings and deeds
03-07-202628 days before the deadline
2025abbreviated format
Gross margin from €237,955 to €293,299Profit of €16,845, after a lossStaff from 3 FTE to 2.7 FTECash from €109,049 to €72,456

Key points

from the 2025 annual accounts

Result

€16,845 €16,845
-€48,5002024€16,8002025

Back in profit in 2025, after a loss of €48,514 in 2024.

Debts

€700,285 75% of the balance sheet
Financial debts 62%Suppliers 20%Taxes and wages 4%Other 14%

Of this, €258,163 falls due within a year.

Filings

36 annual accounts since 1990
AprilJune31 JulyOctober1990200020102020

Seven of the last ten came late. The 2019 accounts came in latest, 33 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,986 companies had the same profile as FARMACON has now. Each dot stands for 10 companies, two years later.

96.4%
were still trading
2.3%
stopped another way
1.1%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,986 companies, not a prediction for FARMACON. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
Director
  • 99.73%score equity €395,746 (2025) · annual accounts 30-06-2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0439169181
Capital increase of €585,000 to €1,170,000 The capital rose from €585,000 to €1,170,000 · Capital contribution: inbreng gedeelte vaststaande schuldvordering rekening-courant · (director) and (director) reappointed · General meeting of 27-02-2024 · Gazette deed
Capital increase of €191,250 to €585,000 The capital rose from €393,750 to €585,000 · General meeting of 08-07-2013 · Gazette deed
Capital increase of €375,150 to €393,750 The capital rose from €18,600 to €393,750 · appointed as manager · and act as permanent representatives · Gazette deed
All 48 events

Comparable companies

same main activity, similar in size and age
Company
FARMACON Lokeren €0.9m €293,299 24.7% 2.7
APOTHEEK ACANTHUS Beveren-Kruibeke-Zwijndrecht €1.0m €281,144 84.1% 2.4
APOTHEEK SPYSSCHAERT Malle €0.9m €330,623 44.9% 3
Apotheek Centrum Schelle Schelle €0.9m €264,499 26.3% 3
APOTHEEK PALMANS Lanaken €1.0m €294,749 27.6% 2.3
APOTHEEK GREET VANMEIRHAEGHE ZINGEM Kruisem €1.1m €336,983 14.6% 3
HERTECANT FARMA Berlare €1.2m €282,416 58.1% 2.5

These companies have the same main activity as FARMACON: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €885,000 and €1.2m, founded between 1988 and 1989.

Official details

Source: KBO
Status
Active since 15-12-1989Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.046.337.6359160 Lokeren, since 03-01-1990
Financial year end
31 December
Peppol
Reachable since 10-04-2024
Company details

Annual accounts 2025

≈ €1.0mestimated
€929,902▼ 9.5%
Employeeson 31-12-2025
3=
Filing
Filed on 03-07-2026, 28 days before the end of the filing period
Financials

Insights on FARMACON

FARMACON files the abbreviated format. That format states no turnover. The gross margin rose from €158,692 in 2006 to €293,299 in 2025.

The balance sheet grew most from 2021 to 2022 through fixed assets.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about FARMACON

What is the company number of FARMACON?
The company number of FARMACON is 0439.169.181. The VAT number is the same number with BE in front: BE 0439.169.181.
Where is FARMACON based?
The registered office is at Gentse Steenweg 450, 9160 Lokeren.Company details
What does FARMACON do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of FARMACON?
FARMACON is a private limited company (BV).
When was FARMACON founded?
FARMACON was founded on 15-12-1989.
Is FARMACON still active?
Yes, FARMACON is an active enterprise in the KBO register.
How many employees does FARMACON have?
FARMACON had an average of 2.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does FARMACON fall under?
In its 2025 annual accounts, FARMACON states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of FARMACON?
The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €293,299 and 42 comparable companies (NACE 477). It probably lies between €800,000 and €1.4m.
Is FARMACON profitable?
In financial year 2025, FARMACON made a profit of €16,845.
Where can I find the annual accounts of FARMACON?
FARMACON filed 36 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of FARMACON due?
FARMACON must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.